| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.54 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |